# Atropine

## Atropine sulfate inj 1mg/1mL

##### 

| TAH Drug Code      | [IATR](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IATR)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Bradycardia, Organophosphorus poisoning, Premed in anesth, Poisoning or overdosage w/ compd having muscarinic actions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Adult : IV/IM/SC Antimuscarinic 400-600mcg every 4-6 hours. IV Anti-arrhythmia 400 mcg-1mg every 1-2 hours. Maximum: 2 mg. IM Premedication in anesthesia 200-600 mcg 30-60 minutes before anesthesia. IM Gastrointestinal endoscopy: 1 mg. IV/IM Organophosphorus poisoning: 1-2 mg every 20-30 minutes until cyanosis disappear or atropine toxicity appears. IV/IM Poisoning or overdosage with compound having muscarinic actions 1-2 mg, repeat 1 hourly until the breathing effect occurs. Children: SC Antimuscarinic 10mcg/kg or 0.3mg/m2 (Body surface area) every 4-6 hours. Maximum: 400mcg. IV Anti-arrhythmia 10-30mcg/kg. SC before anesthesia: <3 kg: 100mcg, 7-9 kg: 200mcg, 12-16 kg: 300mcg, 20-27 kg: 400mcg, 32 kg: 500mcg, 41 kg: 600mcg. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Glaucoma, chronic respiratory disease, sick sinus syndrome, thyrotoxicosis, cardiac failure, pyloric stenosis, prostatic hypertrophy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Dry mouth, dysphagia, constipation, flushing and dryness of skin, tachycardia, palpitations, arrhythmias, mydriasis, photophobia, cycloplegia, raised intraocular pressure. Toxic doses cause tachycardia, hyperpyrexia, restlessness, confusion, excitement, hallucinations, delirium and may progress to circulatory failure and resp depression. Eye drops: Systemic toxicity esp in children, on prolonged use may lead to irritation, hyperaemia, oedema and conjunctivitis. Increased intraocular pressure. Inhalation: Dryness of mouth, throat.                                                                                                                                                                                                        |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

